529 filings
Page 22 of 27
8-K
v043a
24 Mar 16
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
424B4
jqa33 3c7o1
21 Mar 16
Prospectus supplement with pricing info
12:00am
8-K
qj594h7rm
18 Mar 16
Heat Biologics Announces Public Offering of Common Stock and Warrants
12:00am
S-1MEF
vv5bse 23y
18 Mar 16
Registration of additional securities for an S-1
12:00am
EFFECT
fpewtm4bxmw
17 Mar 16
Notice of effectiveness
12:00am
8-K
rul hymzp3557u
16 Mar 16
Regulation FD Disclosure
12:00am
CORRESP
2mps4src0m2sxoq yi6n
15 Mar 16
Correspondence with SEC
12:00am
CORRESP
dgty4sm 57kn5xc
15 Mar 16
Correspondence with SEC
12:00am
8-K
grb8mxtg2hz 3t2
3 Mar 16
Entry into a Material Definitive Agreement
12:00am
8-K
bm2q9m09x41eakc6
25 Feb 16
Heat Biologics Provides Update on its HS-410 Phase 2 Monotherapy Bladder Cancer Trial Arm
12:00am
8-K
i5zah b5umfbvmyw20vh
23 Feb 16
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
l3p7k0tovpseo 3jg
18 Feb 16
Heat Biologics Reports Fiscal Year 2015 Financial Results
12:00am
UPLOAD
02uqru4r
3 Feb 16
Letter from SEC
12:00am
8-K
2ue yae2n4a27i4a9uj
27 Jan 16
Regulation FD Disclosure
12:00am